Sangamo Therapeutics, Inc. (SGMO)
0.119
-0.01
(-10.39%)
USD |
NASDAQ |
Apr 30, 16:00
0.118
0.00 (0.00%)
After-Hours: 20:00
Sangamo Therapeutics Profit Margin (Quarterly) : -263.0% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AngioDynamics, Inc. | -10.31% |
| Precipio, Inc. | 7.85% |
| INmune Bio, Inc. | -- |
| Agenus, Inc. | -31.03% |
| Curis, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.57K% |
| Return on Assets | -140.3% |
| Return on Invested Capital | -360.8% |
| Gross Profit Margin (Quarterly) | 86.77% |
| Operating Margin (Quarterly) | -175.5% |
| Return on Net Operating Assets | -427.2% |